TransMedics Group
Update in progressTMDX (NasdaqGM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
TransMedics Group, Inc. is a commercial-stage medical technology company transforming organ transplant therapy. It offers the Organ Care System (OCS), a portable perfusion and monitoring platform that recreates near-physiologic conditions for donor organs outside the body. OCS LUNG, OCS Heart and OCS Liver preserve lungs, hearts and livers. The company also provides a national OCS program and logistics services, founded in 1998 and based in Andover, MA.
Company score
- Sentiment
- 0.15
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.08
- Governance
- -0.31
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.04
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.06
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGM (NGM)
- LocationUnited States
- CEODr. Waleed H. Hassanein M.D.
- Founded1998
- Employees898
- Websitewww.transmedics.com
Identifiers
- ISINUS89377M1099
- FIGIBBG00NZ6J685
- CUSIP89377M109
- CIK0001756262